Literature DB >> 18787777

Toll like receptor-2 modulates both innate and adaptive immune responses during chronic fungal asthma in mice.

K F Buckland1, E O'Connor, L A Murray, C M Hogaboam.   

Abstract

OBJECTIVE AND
DESIGN: We investigated the effect of TLR2 gene deletion in a murine model of chronic fungal asthma.
METHODS: TLR2 wildtype (TLR2(+/+)) and TLR2 deficient (TLR2(-/-)) mice were sensitized to soluble A. fumigatus antigens and challenged with live A. fumigatus conidia, and the extent of allergic airways disease was analyzed in both groups of mice at 3, 7, 14, and 30 days after conidia.
RESULTS: At day 7 post-conidia, TLR2(-/-) mice exhibited significantly lower airway hyperresponsiveness, airway inflammation, and whole lung Th2 cytokine levels compared with the TLR2(+ / +) group. TLR2 deletion also significantly reduced mucus cell metaplasia and peribronchial fibrosis at day 30 after conidia. However, fungal material persisted in the TLR2(-/-) group, and at day 30 after conidia TLR2(-/-) mice exhibited enhanced airway neutrophil recruitment and airway hyperresponsiveness.
CONCLUSION: Thus, during chronic fungal asthma in mice, TLR2 is a major contributor to the maintenance of the adaptive Th2-cytokine driven and anti-fungal innate responses.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18787777     DOI: 10.1007/s00011-008-8004-y

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  10 in total

1.  Innate signals from Nod2 block respiratory tolerance and program T(H)2-driven allergic inflammation.

Authors:  Wei Duan; Amit K Mehta; Joao G Magalhaes; Steven F Ziegler; Chen Dong; Dana J Philpott; Michael Croft
Journal:  J Allergy Clin Immunol       Date:  2010-11-04       Impact factor: 10.793

2.  TLR2 Regulates Allergic Airway Inflammation and Autophagy Through PI3K/Akt Signaling Pathway.

Authors:  Xuqin Jiang; Lei Fang; Huimei Wu; Xiaodong Mei; Fang He; Peishan Ding; Rongyu Liu
Journal:  Inflammation       Date:  2017-08       Impact factor: 4.092

3.  Expression of toll-like receptors 2 and 3 on esophageal epithelial cell lines and on eosinophils during esophagitis.

Authors:  Daniel J Mulder; David Lobo; Nanette Mak; Christopher J Justinich
Journal:  Dig Dis Sci       Date:  2011-09-30       Impact factor: 3.199

4.  Triggering receptor expressed on myeloid cells-1 (TREM-1) modulates immune responses to Aspergillus fumigatus during fungal asthma in mice.

Authors:  Karen F Buckland; Hemanth Ramaprakash; Lynne A Murray; Kristin J Carpenter; Esther S Choi; Steven L Kunkel; Nicholas W Lukacs; Zhou Xing; Naoko Aoki; Dominik Hartl; Cory M Hogaboam
Journal:  Immunol Invest       Date:  2011-05-19       Impact factor: 3.657

5.  Effects of the TLR2 agonists MALP-2 and Pam3Cys in isolated mouse lungs.

Authors:  Martina Barrenschee; Dennis Lex; Stefan Uhlig
Journal:  PLoS One       Date:  2010-11-16       Impact factor: 3.240

Review 6.  Toll-like receptors, triggering receptor expressed on myeloid cells family members and receptor for advanced glycation end-products in allergic airway inflammation.

Authors:  Sannette C Hall; Devendra K Agrawal
Journal:  Expert Rev Respir Med       Date:  2016-01-20       Impact factor: 3.772

Review 7.  The Role of Airway Epithelial Cell Alarmins in Asthma.

Authors:  Christiane E Whetstone; Maral Ranjbar; Hafsa Omer; Ruth P Cusack; Gail M Gauvreau
Journal:  Cells       Date:  2022-03-24       Impact factor: 6.600

Review 8.  Fungal pathogens-a sweet and sour treat for toll-like receptors.

Authors:  Christelle Bourgeois; Karl Kuchler
Journal:  Front Cell Infect Microbiol       Date:  2012-11-22       Impact factor: 5.293

Review 9.  Dual Role of Toll-like Receptors in Human and Experimental Asthma Models.

Authors:  Amin Zakeri; Momtchilo Russo
Journal:  Front Immunol       Date:  2018-05-15       Impact factor: 7.561

10.  Toll-like receptor 2 and facial motoneuron survival after facial nerve axotomy.

Authors:  Derek A Wainwright; Junping Xin; Nichole A Mesnard; Virginia M Sanders; Kathryn J Jones
Journal:  Neurosci Lett       Date:  2010-01-05       Impact factor: 3.046

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.